1.New Paradigm for Treatment of Chronic Hepatitis C Virus Infection.
The Korean Journal of Gastroenterology 2013;62(1):78-81
No abstract available.
Female
;
Gastroparesis/*diagnosis
;
Hernia, Diaphragmatic/*diagnosis
;
Humans
;
Stomach Volvulus/*diagnosis
2.Vomiting.
The Korean Journal of Gastroenterology 2017;70(6):283-287
Many disorders can cause either acute or chronic vomiting. However, in most cases, vomiting is self-limited. A correct diagnosis is possible by conducting careful histories and physical examinations. In cases of severe vomiting, further testing, including laboratory studies, radiological images, endoscopic evaluation, and gastrointestinal motility tests, can also be considered. The correction of clinical consequences of vomiting should be initiated, including dehydration, electrolyte imbalances, malnutrition, and suppression of symptoms via the use empirical antiemetic treatments. Moreover, underlying disorders should be treated using dietary, pharmacological, and even surgical interventions.
Dehydration
;
Diagnosis
;
Gastrointestinal Motility
;
Gastroparesis
;
Malnutrition
;
Physical Examination
;
Vomiting*
3.Clinical analysis of gastroparesis syndrome after nongastrectomy abdominal operation: a report of 22 cases.
Wei-liang YANG ; Chao-qi YAN ; Dong-wei ZHANG ; Yu-lin MA
Chinese Journal of Gastrointestinal Surgery 2006;9(4):305-307
OBJECTIVETo investigate the causes, diagnosis and treatment of gastroparesis syndrome after nongastrectomy abdominal operation.
METHODSThe clinical data of 22 cases with gastroparesis syndrome after nongastrectomy abdominal operation from 1972 to 2004 were retrospectively analyzed.
RESULTSGastroparesis syndrome after nongastrectomy abdominal operation often occurred during 4-6 days postoperatively when the patients began to take in food, characterized by upper abdominal distension, nausea, vomiting, strong splashing bowel sound, weak bowel sound and large quantity of gastric drainage ranging from 1000 to 3000 ml every day. Barium meal was valuable not only in the diagnosis but also effective for promoting gas motility. It revealed a non-peristaltic, flabby and static stomach, and retention of contrast medium in the stomach even 5-6 hours later. All the patients recovered through non-operative therapy for 5-25 days including continuous gastrointestinal decompression, TPN and gastro-intestinal dynamic medicine.
CONCLUSIONSThe causes of gastroparesis syndrome after nongastrectomy abdominal operation are multifactorial, most of such patients can be cured by non-operative therapy.
Abdominal Cavity ; surgery ; Adult ; Aged ; Female ; Gastroparesis ; diagnosis ; etiology ; therapy ; Humans ; Male ; Middle Aged ; Retrospective Studies
4.Gastroparesis Updates on Pathogenesis and Management.
Gut and Liver 2017;11(5):579-589
Gastroparesis (Gp) is a chronic disease that presents with clinical symptoms of early satiety, bloating, nausea, vomiting, and abdominal pain. Along with these symptoms, an objective finding of delayed gastric emptying, along with a documented absence of gastric outlet obstruction, are required for diagnosis. This article focuses on updates in the pathogenesis and management of Gp. Recent studies on full thickness biopsies of Gp patients have shed light on the complex interactions of the central, autonomic, and enteric nervous systems, which all play key roles in maintaining normal gut motility. The management of Gp has evolved beyond prokinetics and antiemetics with the use of gastric electrical stimulators (GES). In addition, this review aims to introduce the concept of gastroparesis-like syndrome (GLS). GLS helps groups of patients who have the cardinal symptoms of Gp but have a normal or rapid emptying test. Recent tests have shown that patients with Gp and GLS have similar pathophysiology, benefit greatly from GES placement, and likely should be treated in a similar manner.
Abdominal Pain
;
Antiemetics
;
Biopsy
;
Chronic Disease
;
Diagnosis
;
Enteric Nervous System
;
Gastric Emptying
;
Gastric Outlet Obstruction
;
Gastroparesis*
;
Humans
;
Nausea
;
Vomiting
5.Gastroparesis Updates on Pathogenesis and Management.
Gut and Liver 2017;11(5):579-589
Gastroparesis (Gp) is a chronic disease that presents with clinical symptoms of early satiety, bloating, nausea, vomiting, and abdominal pain. Along with these symptoms, an objective finding of delayed gastric emptying, along with a documented absence of gastric outlet obstruction, are required for diagnosis. This article focuses on updates in the pathogenesis and management of Gp. Recent studies on full thickness biopsies of Gp patients have shed light on the complex interactions of the central, autonomic, and enteric nervous systems, which all play key roles in maintaining normal gut motility. The management of Gp has evolved beyond prokinetics and antiemetics with the use of gastric electrical stimulators (GES). In addition, this review aims to introduce the concept of gastroparesis-like syndrome (GLS). GLS helps groups of patients who have the cardinal symptoms of Gp but have a normal or rapid emptying test. Recent tests have shown that patients with Gp and GLS have similar pathophysiology, benefit greatly from GES placement, and likely should be treated in a similar manner.
Abdominal Pain
;
Antiemetics
;
Biopsy
;
Chronic Disease
;
Diagnosis
;
Enteric Nervous System
;
Gastric Emptying
;
Gastric Outlet Obstruction
;
Gastroparesis*
;
Humans
;
Nausea
;
Vomiting
6.Methanogens, Methane and Gastrointestinal Motility.
Konstantinos TRIANTAFYLLOU ; Christopher CHANG ; Mark PIMENTEL
Journal of Neurogastroenterology and Motility 2014;20(1):31-40
Anaerobic fermentation of the undigested polysaccharide fraction of carbohydrates produces hydrogen in the intestine which is the substrate for methane production by intestinal methanogens. Hydrogen and methane are excreted in the flatus and in breath giving the opportunity to indirectly measure their production using breath testing. Although methane is detected in 30%-50% of the healthy adult population worldwide, its production has been epidemiologically and clinically associated with constipation related diseases, like constipation predominant irritable bowel syndrome and chronic constipation. While a causative relation is not proven yet, there is strong evidence from animal studies that methane delays intestinal transit, possibly acting as a neuromuscular transmitter. This evidence is further supported by the universal finding that methane production (measured by breath test) is associated with delayed transit time in clinical studies. There is also preliminary evidence that antibiotic reduction of methanogens (as evidenced by reduced methane production) predicts the clinical response in terms of symptomatic improvement in patients with constipation predominant irritable bowel syndrome. However, we have not identified yet the mechanism of action of methane on intestinal motility, and since methane production does not account for all constipation associated cases, there is need for high quality clinical trials to examine methane as a biomarker for the diagnosis or as a biomarker that predicts antibiotic treatment response in patients with constipation related disorders.
Adult
;
Animals
;
Breath Tests
;
Carbohydrates
;
Constipation
;
Diagnosis
;
Fermentation
;
Flatulence
;
Gastrointestinal Motility*
;
Gastroparesis
;
Humans
;
Hydrogen
;
Intestines
;
Irritable Bowel Syndrome
;
Methane*
;
Methanococcus
8.How to Assess Regional and Whole Gut Transit Time With Wireless Motility Capsule.
Yeong Yeh LEE ; Askin ERDOGAN ; Satish S C RAO
Journal of Neurogastroenterology and Motility 2014;20(2):265-270
Assessment of transit through the gastrointestinal tract provides useful information regarding gut physiology and pathophysiology. Although several methods are available, each has distinct advantages and limitations. Recently, an ingestible wireless motility capsule (WMC), similar to capsule video endoscopy, has become available that offers a less-invasive, standardized, radiation-free and office-based test. The capsule has 3 sensors for measurement of pH, pressure and temperature, and collectively the information provided by these sensors is used to measure gastric emptying time, small bowel transit time, colonic transit time and whole gut transit time. Current approved indications for the test include the evaluation of gastric emptying in gastroparesis, colonic transit in constipation and evaluation of generalised dysmotility. Rare capsule retention and malfunction are known limitations and some patients may experience difficulty with swallowing the capsule. The use of WMC has been validated for the assessment of gastrointestinal transit. The normal range for transit time includes the following: gastric emptying (2-5 hours), small bowel transit (2-6 hours), colonic transit (10-59 hours) and whole gut transit (10-73 hours). Besides avoiding the use of multiple endoscopic, radiologic and functional gastrointestinal tests, WMC can provide new diagnoses, leads to a change in management decision and help to direct further focused work-ups in patients with suspected disordered motility. In conclusion, WMC represents a significant advance in the assessment of segmental and whole gut transit and motility, and could prove to be an indispensable diagnostic tool for gastrointestinal physicians worldwide.
Colon
;
Constipation
;
Deglutition
;
Diagnosis
;
Endoscopy
;
Gastric Emptying
;
Gastrointestinal Motility
;
Gastrointestinal Tract
;
Gastrointestinal Transit
;
Gastroparesis
;
Humans
;
Hydrogen-Ion Concentration
;
Physiology
;
Reference Values
9.Nutrition Management of Patients with Diabetic Gastroparesis.
Journal of Korean Diabetes 2018;19(3):180-185
Gastroparesis is one of complications in diabetic patients which need different management with diabetic patients without complication. Diabetic gastroparesis is a chronic disease and has clinical symptoms such as early satiety, nausea, vomiting and abdominal pain. Patients with diabetic gastroparesis have a high risk of malnutrition, which may result in poor quality of life. Therefore, in patients with have a gastrointestinal disorder, such as delayed gastric emptying in the early stages of malnutrition, we should consider diagnosis and management for diabetic gastroparesis. This review focused on diagnosis, symptoms and proper nutritional management of patients with diabetic gastroparesis. To reduce gastrointestinal disorders, patients with diabetic gastroparesis provide information on the type of food, the number of meals, the intake of fats, the intake of dietary fiber, and the intake of vitamin minerals.
Abdominal Pain
;
Chronic Disease
;
Diabetes Mellitus
;
Diagnosis
;
Dietary Fiber
;
Fats
;
Gastric Emptying
;
Gastroparesis*
;
Humans
;
Malnutrition
;
Meals
;
Minerals
;
Miners
;
Nausea
;
Quality of Life
;
Vitamins
;
Vomiting
10.Adenocarcinoma of the Proximal Jejunum Misdiagnosed as Gastroparesis
Hyung Keun KIM ; Min Jae CHO ; Soyoung HA ; Min Ji SEO ; Sang Gon MOON ; Jung Hwan OH
The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2019;19(3):202-206
The prevalence of small bowel cancer is relatively low. The abdominal pain that patients with small bowel cancer present as a symptom is non-specific and often interpreted as a normal finding on radiographic studies. To prevent delayed diagnosis of small bowel cancer, practitioners must maintain a certain level of suspicion. We report a case of delayed diagnosis of jejunal cancer as it was misdiagnosed as gastroparesis. A 69-year-old woman complained of recurrent nausea and vomiting. At the beginning of her hospitalization, we could not diagnose mechanical obstruction through esophagogastroduodenoscopy and abdominal computed tomography. A gastric emptying study revealed delayed gastric emptying. Although the patients received treatments, including administration of prokinetics and botulinum toxin injection, for gastroparesis, her symptoms aggravated. Subsequently, plain radiography of the abdomen revealed a double-bubble sign. Abdominal computed tomography was performed under the suspicion of small bowel obstruction; however, the diagnosis was not clear. Consequently, exploratory laparoscopy was performed. She underwent surgical management, including small bowel segmental resection and duodenojejunostomy, due to the jejunal mass with involvement of the stomach, pancreatic head, and mesentery of the transverse colon. The postoperative pathological results revealed a moderately differentiated adenocarcinoma of the jejunum.
Abdomen
;
Abdominal Pain
;
Adenocarcinoma
;
Aged
;
Botulinum Toxins
;
Colon, Transverse
;
Delayed Diagnosis
;
Diagnosis
;
Endoscopy, Digestive System
;
Female
;
Gastric Emptying
;
Gastroparesis
;
Head
;
Hospitalization
;
Humans
;
Jejunal Neoplasms
;
Jejunum
;
Laparoscopy
;
Mesentery
;
Nausea
;
Prevalence
;
Radiography
;
Stomach
;
Vomiting